Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal Progesterone for Preterm Birth in Twins with Short Cervix
NCT01812239Phase 3Withdrawn
- Sponsor
- Obstetrix Medical Group
- Start
- Mar 2014
- Primary completion
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Crinone in preterm birth, sponsored by Obstetrix Medical Group. Planned start Mar 2014; status: withdrawn.
02
Drugs
Crinone
03
Conditions
preterm birth
Beyond the preview
Go deeper on NCT01812239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01812239.